What are the diagnostic criteria for IgG4‑related disease presenting with mediastinal lymphadenopathy and pulmonary nodules?

Diagnostic Criteria for IgG4-Related Disease with Mediastinal Lymphadenopathy and Pulmonary Nodules

The diagnosis of IgG4-related disease (IgG4-RD) presenting with mediastinal lymph nodes and lung nodules requires a combination of elevated serum IgG4 levels (>1.35 g/dL), characteristic histopathology showing >10 IgG4-positive plasma cells per high-power field with an IgG4+/IgG+ ratio >40%, and exclusion of malignancy and other inflammatory conditions through tissue biopsy. 1, 2

Clinical Presentation

• IgG4-RD with thoracic involvement typically affects middle-aged to elderly men and presents with nonspecific symptoms including dyspnea, cough, or chest pain. 3, 4
• Thoracic manifestations occur in up to 30% of patients with systemic IgG4-RD, and represent the exclusive disease manifestation in approximately 10% of cases. 4
• Obstructive symptoms may be present when mediastinal lymphadenopathy causes compression of adjacent structures. 5

Serological Criteria

• Serum IgG4 elevation (>1.35 g/dL) is present in 50-80% of IgG4-RD patients, but this finding alone is insufficient for diagnosis. 1, 5, 6
• An IgG4/IgG1 ratio >0.24 improves diagnostic specificity when distinguishing IgG4-RD from other inflammatory conditions. 1, 5
• Serum IgG4 levels >4× the upper limit of normal are highly specific for IgG4-related disease. 1, 5
• Normal serum IgG4 does not exclude the diagnosis, as 20-50% of patients have IgG4 levels within the reference range. 7
• Total serum IgG is often elevated in addition to IgG4, and normal white blood cell count with normal C-reactive protein is characteristic. 3

Radiological Features

• Mediastinal lymphadenopathy is a common finding in IgG4-related lung disease, often bilateral and involving multiple nodal stations. 3, 4
• Pulmonary nodules in IgG4-RD may be solitary or multiple, and can demonstrate FDG uptake on PET-CT (median SUV ~5.5), mimicking malignancy. 6, 4
• Characteristic CT patterns include peribronchovascular thickening, thickening of the perilymphatic interstitium, subpleural and/or peribronchovascular consolidation, ground-glass opacities, and nodules. 3, 4
• PET-CT may show uptake in both pulmonary nodules and mediastinal lymph nodes, making differentiation from lung cancer challenging based on imaging alone. 1, 6
• Distribution along lymphatic routes (peribronchovascular and subpleural) is highly characteristic and correlates with pathological findings. 3

Histopathological Criteria (Gold Standard)

• Tissue diagnosis is essential to exclude malignancy (particularly lung cancer and lymphoma) and confirm IgG4-RD. 1, 5, 6
• The diagnostic triumvirate includes: (1) dense lymphoplasmacytic infiltrate, (2) storiform-type fibrosis, and (3) obliterative phlebitis. 2
• Quantitative criteria require >10 IgG4-positive plasma cells per high-power field in affected tissue. 1, 2
• An IgG4+/IgG+ plasma cell ratio >40% is required to improve specificity and distinguish IgG4-RD from other conditions. 1, 2
• Massive lymphoplasmacytic infiltration with fibrosis in and around lymphatic routes is the characteristic pathological pattern in thoracic IgG4-RD. 3
• Emperipolesis is not a feature of IgG4-RD and should prompt consideration of Rosai-Dorfman disease, though some overlap can occur. 8

Diagnostic Algorithm

1. Obtain chest CT with contrast to characterize nodules, lymphadenopathy, and distribution pattern along lymphatic routes. 3, 4

2. Measure serum IgG4 and total IgG levels, with IgG4/IgG1 ratio if available. 1, 5

3. Perform PET-CT to identify multisystem involvement and assess metabolic activity of lesions. 1, 6

4. Search systematically for extrathoracic manifestations including pancreatic involvement (present in >80% of systemic cases), salivary gland enlargement, retroperitoneal fibrosis, and renal lesions. 1, 4

5. Obtain tissue diagnosis through the least invasive approach: CT-guided needle biopsy for accessible nodules, or bronchoscopic biopsy for endobronchial lesions. 6

6. If initial biopsy is non-diagnostic or shows only elevated IgG4+ cells without classical features, proceed to surgical wedge resection to obtain adequate tissue for comprehensive histopathological evaluation. 6, 9

7. Ensure pathology evaluation includes: routine H&E staining, IgG and IgG4 immunohistochemistry with quantification of positive cells per high-power field, and calculation of IgG4+/IgG+ ratio. 2, 9

Critical Differential Diagnoses to Exclude

• Lung cancer (adenocarcinoma, squamous cell carcinoma) is the most important malignant differential, as both can present with nodules and mediastinal lymphadenopathy with PET avidity. 6
• Lymphoma must be excluded, as lymphoproliferative disorders can show similar lymphoplasmacytic infiltrates and elevated IgG4+ cells. 3, 4
• Sarcoidosis presents with mediastinal lymphadenopathy and nodules but shows non-caseating granulomas rather than lymphoplasmacytic infiltrates. 8
• Rosai-Dorfman disease can have IgG4+ plasma cells but is distinguished by S100-positive histiocytes with emperipolesis and requires >10% of specimen showing RDD morphology. 8
• ANCA-associated vasculitis (particularly granulomatosis with polyangiitis) can mimic IgG4-RD but typically shows positive MPO or PR3 antibodies and necrotizing vasculitis. 8, 2

Common Diagnostic Pitfalls

• Do not rely on serum IgG4 elevation alone, as 9-15% of patients with other conditions (including primary sclerosing cholangitis) have elevated IgG4. 7, 1
• Elevated IgG4+ plasma cells in tissue are not specific and can be seen in various inflammatory and neoplastic conditions; the IgG4+/IgG+ ratio >40% is critical. 2
• Not all classical histopathological features may be present in small biopsies; correlation with clinical and radiological findings is essential. 9
• Avoid unnecessary major lung resections by ensuring comprehensive preoperative workup including serum IgG4, PET-CT, and attempted needle biopsy before proceeding to surgery. 6
• The absence of extrathoracic involvement does not exclude IgG4-RD, as isolated thoracic disease occurs in ~10% of cases. 4

Confirmatory Response to Treatment

• A dramatic clinical and radiographic response to corticosteroids within 2-4 weeks (occurring in 62-100% of cases) provides strong supportive evidence for IgG4-RD. 1, 5
• Initial treatment with prednisolone 0.6 mg/kg/day (typically 40 mg daily) for 2-4 weeks followed by gradual taper can serve as both therapeutic and diagnostic intervention when tissue diagnosis is equivocal. 1
• Lack of response to corticosteroids should prompt reconsideration of the diagnosis and exclusion of malignancy or other steroid-resistant conditions. 5